Clinical Trial Update: Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ctDNA-guided treatment for localized pancreatic cancer, comparing neoadjuvant CTX chemotherapy to upfront surgery. The study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• CTX

Snippet

Sponsor: Elisabethinen Hospital | Conditions: Pancreatic Cancer, Circulating Tumor Cell | Phase 3 | Status: RECRUITING